Summary
RENOIR is a European Training Network that brings together 12 beneficiaries (10 academic and 2 industrial), and 3 partner organizations (a private Onlus Foundation, a pharmaceutical company, and a university) to train 13 Early Stage Researchers with an interdisciplinary profile for outstanding carriers as leaders in the field of muscle regeneration and aging.
Receiving a training programme in both scientific and transferable skills and using unique expertise and tools at the frontier between biology and engineering, this new generation of versatile researchers will dissect the cellular and molecular mechanisms underlying impaired muscle composition and function, paving the way to new therapeutic interventions for muscle disease and aging. This will happen through collaborative and synergistic projects between academia and industry.
Receiving a training programme in both scientific and transferable skills and using unique expertise and tools at the frontier between biology and engineering, this new generation of versatile researchers will dissect the cellular and molecular mechanisms underlying impaired muscle composition and function, paving the way to new therapeutic interventions for muscle disease and aging. This will happen through collaborative and synergistic projects between academia and industry.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: | https://cordis.europa.eu/project/id/860034 |
Start date: | 01-05-2020 |
End date: | 30-04-2025 |
Total budget - Public funding: | 3 482 325,18 Euro - 3 482 325,00 Euro |
Cordis data
Original description
RENOIR is a European Training Network that brings together 12 beneficiaries (10 academic and 2 industrial), and 3 partner organizations (a private Onlus Foundation, a pharmaceutical company, and a university) to train 13 Early Stage Researchers with an interdisciplinary profile for outstanding carriers as leaders in the field of muscle regeneration and aging.Receiving a training programme in both scientific and transferable skills and using unique expertise and tools at the frontier between biology and engineering, this new generation of versatile researchers will dissect the cellular and molecular mechanisms underlying impaired muscle composition and function, paving the way to new therapeutic interventions for muscle disease and aging. This will happen through collaborative and synergistic projects between academia and industry.
Status
SIGNEDCall topic
MSCA-ITN-2019Update Date
28-04-2024
Images
No images available.
Geographical location(s)